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A 37-year-old man with AIDS presented with altered mental status four weeks after stopping
his  medications for Mycobacterium avium-intracellulare (MAI). He had low CD4 cell count and
severe hypercalcemia. Bone marrow biopsy revealed bone marrow inﬁltration by granulomas
positive for acid-fast bacilli and cultures grew MAI. His hypercalcemia continued to worsen
with the initiation of MAI therapy but we were able to treat it successfully with pamidronateeywords:
ypercalcemia
IDS
ycobacterium infection
and  calcitonin.
© 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an
open  access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
use. On physical examination, his temperature was 38.1 ◦C,
blood pressure 130/50, heart rate 118, respiratory rate 16 with
O2 saturation 95% on room temperature. He was somnolent
and cachectic.ntroduction
ypercalcemia above 14 mg/dL is often attributed to malig-
ancy, but patients with HIV warrant further investigation
nto opportunistic infections such as Mycobacterium avium-
ntracellulare (MAI). Although previous reports discussed the
ssociation between MAI  and hypercalcemia, the onset and
linical course of hypercalcemia is not known. We  present
 case of hypercalcemia with MAI  that worsened with the
nitiation of anti-mycobacterial therapy and a review of the
iterature of the onset of hypercalcemia in relation with MAI
iagnosis and explore potential triggers.Please cite this article in press as: Ayoubieh H, Alkhalili E. Mycobacterium a
an AIDS patient. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.201
Abbreviations: HIV, human immunodeﬁciency virus; AIDS, acquired 
herapy; MAI, Mycobacterium avium intracellulare; CT, computed tomogra
oagulation.
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A 37-year-old man  with AIDS on highly active antiretroviral
therapy (HAART) and chronic therapy for Mycobacterium avium-
intracellulare (MAI) presented with altered mental status four
weeks after stopping his medications. His family reported pro-
gressive confusion and weight loss. He did not have any recent
history of sick contacts, travel, animal exposure, nor illicit drugvium-intracellulare and the unpredictable course of hypercalcemia in
6.08.002
immunodeﬁciency syndrome; HAART, highly active antiretroviral
phy; MRI, magnetic resonance imaging; DIC, diffuse intravascular
m (H. Ayoubieh), ealkhalili@salud.unm.edu (E. Alkhalili).
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Fig. 1 – Magnetic resonance imaging of the brain showing
areas of abnormal parenchymal signal intensity (arrows)
involving cortex and subcortical white matter within the
syndrome (IRIS) against MAI.6 Four reports described hyper-frontal lobes, right temporal lobe, and left insula.
Laboratory work-up showed normocytic anemia with
a hemoglobin of 8 g/dL, leukopenia 0.9/L thrombocy-
topenia 60/L, CD4 count 7/mm3, creatinine 1.4 mg/dL,
corrected calcium 12 mg/dL (ref 8.4–10.4 mg/dL), ionized cal-
cium 1.6 mmol/L (ref 1.15–1.27 mmol/L), phosphorus 2 mg/dL
(ref 2.3–5.6), and albumin 1.8 g/dL (ref 3.5–5 d/dL). His 25-
hydroxycalciferol level was low 9 ng/ml (ref 30–100), PTH was
suppressed 6 pg/mL (ref 11–80 pg/mL) and PTH-related peptide
was undetectable.
Magnetic resonance imaging (MRI) of the brain showed
scattered areas of abnormal parenchymal signal intensity
likely from tuberculous meningoencephalitis (Fig. 1). Com-
puted tomography (CT) of the chest, abdomen and pelvisPlease cite this article in press as: Ayoubieh H, Alkhalili E. Mycobacterium a
an AIDS patient. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.201
revealed necrotic mesenteric lymph nodes and splenomegaly.
Serum protein electrophoresis and skeletal survey were
negative. Bone marrow biopsy revealed bone marrow
Table 1 – Previous reports of MAI-associated hypercalcemia.
Study Timeframe of MAI diagnosis
in relation to hypercalcemia
Potentia
Tsao et al.6 At presentation Starting HAART
of IRIS
Shrayyef et al.3 At presentation Initiation of vit
supplementati
Choudhary et al.7 Six months prior Changes in MA
Playford et al.8
Case 1 Four months prior Changes in MA
Case 2 Four weeks prior Initiating MAI 
Aly et al.4 At presentation Six months aft
Newell et al.12 Six months prior Unknown 
Delahunt et al.5 At presentation Unknown  6;x x x(x x):xxx–xxx
inﬁltration by granulomas positive for acid-fast bacilli and
cultures grew MAI. His hypercalcemia was treated with intra-
venous ﬂuids and he was started on clarithromycin, rifampin
and ethambutol for MAI. His serum calcium trended up from
12 mg/dL on admission to 14 mg/dL by hospital day six so
he was started on calcitonin and pamidronate with normal-
ization of serum calcium and improvement in the patient’s
mental status within 24 h.
The patient’s calcium levels remained within normal
range but his clinical condition deteriorated as he developed
severe sepsis, disseminated intravascular coagulation (DIC),
and respiratory failure requiring endotracheal intubation and
mechanical ventilation secondary to hospital-acquired pneu-
monia. A follow-up brain CT showed worsening in the size
of the lesions secondary to hemorrhage in the setting of DIC.
After extubation, he was found to have major cognitive deﬁcits
with being oriented only to self. At the time of discharge, his
hypercalcemia, sepsis, and DIC have all resolved, however, his
cognitive impairment persisted.
Discussion
Between 1981 and 1987, 5.5% of AIDS cases reported to
the Centers for Disease Control (CDC) had non-tuberculous
mycobacterial infection, with MAI being the culprit in 96% of
cases.1 The incidence of opportunistic infections decreased
with the advent of HAART and a more  recent study from 1994
to 2007 suggested that the rate of Mycobacterium avium com-
plex infection is 2.5 per 1000 person-years in individuals with
AIDS.2 The mechanism of hypercalcemia in granulomatous
disease is thought to be related to vitamin D dysregulation
but this does not always correlate with vitamin D metabolite
levels.3
A review of the literature yielded only eight cases of
MAI-associated hypercalcemia (Table 1). Three of these cases
presented with hypercalcemia at the time of diagnosis of
MAI3–5; Tsao et al. described hypercalcemia presenting as
part of the spectrum of immune reconstitution inﬂammatoryvium-intracellulare and the unpredictable course of hypercalcemia in
6.08.002
calcemia in patients who were undergoing treatment for MAI,
soon after starting or changing antimicrobial therapy.7,8 One
patient was diagnosed three weeks after initiating treatment
l hypercalcemia trigger Hypercalcemia treatment
 with subsequent development Steroids
amin D and calcium
on three weeks prior
Unknown
I therapy Steroids
I therapy Bisphosphonate
therapy Bisphosphonate
er starting HAART Bisphosphonate
Bisphosphonate
Bisphosphonate and steroids
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HIV-related osteoporosis. Endocrine. 2015;48:358–9.
12. Newell A, Nelson MR. Hypercalcaemia in a patient with AIDSb  r a z j i n f e c t d i s .
or vitamin D deﬁciency.3 Our patient presented with hyper-
alcemia at the time of diagnosis, which worsened within
ays of restarting MAI  therapy. In all these cases, no associ-
tion between the development of hypercalcemia and organ
nvolvement or choice of anti-MAI therapy was observed.
The suggested treatment of hypercalcemia in granuloma-
ous disease is steroids which are thought to downregulate
alcitriol synthesis by macrophages.9 Given our concern for
ymphoma as part of our differential diagnosis, we elected
ot to use steroids as they cause histopathological alterations
n biopsy and delay in making the diagnosis.10 Our patient
as treated with calcitonin and pamidronate. Bisphospho-
ates can be safely used for the treatment of osteoporosis in
IV patients,11 and Shrayef et al. previously used pamidronate
uccessfully for the treatment of hypercalcemia with MAI.3
It is unknown if there is a genetic predisposition for some
ndividuals with AIDS who  are infected with MAI  to develop
ypercalcemia. Our review of the literature suggests that
ertain triggers may be implicated such as immune reconstitu-
ion after starting HAART, improved host defence mechanism
fter initiating or incurring change in anti-MAI therapy or dys-
egulated response to vitamin D treatment.
onclusions
hile hypercalcemia is a known complication of granuloma-
ous disease, clinicians should be aware of the variability in
resentation of hypercalcemia with MAI, whether as the ﬁrst
anifestation or a late presenter in the disease course. As
e showed in this case, hypercalcemia may worsen within
ays of initiating anti-mycobacterial therapy. We  suggest care-
ul monitoring of serum calcium levels upon diagnosis of
AI infection and after initiation of mycobacterial therapy or
itamin D supplementation. Pamidronate and calcitonin are
cceptable treatment alternatives to steroids for hypercalemia
reatment.Please cite this article in press as: Ayoubieh H, Alkhalili E. Mycobacterium a
an AIDS patient. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bjid.201
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